title: Flutamide Enhances Neuroprotective Effects of Testosterone during Experimental Cerebral Ischemia in Male Rats.
abstract: Testosterone has been shown to worsen histological and neurological impairment during cerebral ischemia in animal models. Cell culture studies revealed that testosterone is implicated in protecting neural and glial cells against insults, and they started to elucidate testosterone pathways that underlie these protective effects. These studies support the hypothesis that testosterone can be neuroprotective throughout an episode of cerebral ischemia. Therefore, we evaluated the mechanisms underlying the shift between testosterone protective and deleterious effects via block testosterone aromatization and androgen receptors in rats subjected to 60-minute middle cerebral artery occlusion. Fifty rats were divided into five equal groups: gonadally intact male; castrated male; intact male + flutamide; intact male + letrozole; intact male + combination flutamide and letrozole. Our results indicated that castration has the ability to reduce histological damage and to improve neurological score 24 hours after middle cerebral artery occlusion. Moreover, flutamide improved histologic and neurological impairment better than castration. Letrozole induced increases in striatal infarct volume and seizures in gonadally intact rats. Combination of flutamide and letrozole showed that letrozole can reverse beneficial effects of flutamide. In conclusion, it seems that the beneficial effects of flutamide are the prevention of the deleterious effects and enhancement of neuroprotective effects of testosterone during cerebral ischemia.
authors: Department of Physiology, Medical School, Tehran University of Medical Sciences, Enghelab Street, Tehran 1411413137, Iran.
authors: Hamed
authors: H
authors: Fanaei
authors: Hamid Reza
authors: HR
authors: Sadeghipour
authors: Seyed Morteza
authors: SM
authors: Karimian
authors: Gholamreza
authors: G
authors: Hassanzade
references: J Neurochem. 2004 Mar;88(5):1179-85
references: 15009673
references: Minerva Endocrinol. 2010 Jun;35(2):127-43
references: 20595940
references: Brain Res. 2005 May 10;1043(1-2):195-204
references: 15862533
references: Brain Res. 2012 Jan 9;1430:86-92
references: 22099262
references: Stroke. 2001 Nov;32(11):2559-66
references: 11692017
references: Mol Cell Endocrinol. 2002 Dec 30;198(1-2):97-103
references: 12573819
references: J Neurosci Nurs. 2010 Apr;42(2):80-7
references: 20422793
references: Neurosci Lett. 2012 Jan 6;506(1):1-6
references: 22133807
references: Horm Behav. 2008 May;53(5):693-705
references: 18222446
references: Endocrine. 2006 Apr;29(2):217-31
references: 16785598
references: Brain Res. 2001 Nov 16;919(1):160-5
references: 11689174
references: J Neuroendocrinol. 2008 Jun;20(6):705-12
references: 18601693
references: Brain Res. 2007 Aug 24;1165:21-9
references: 17662261
references: Anesth Analg. 2008 Jul;107(1):201-14
references: 18635489
references: Stroke. 1998 Aug;29(8):1666-70
references: 9707210
references: J Neurobiol. 2005 Feb 15;62(3):341-51
references: 15514992
references: Brain Res. 1998 Jun 15;796(1-2):296-8
references: 9689481
references: Exp Neurol. 2007 Jan;203(1):72-81
references: 17005180
references: Neuroscience. 2010 Aug 25;169(2):758-69
references: 20580788
references: Womens Health (Lond). 2010 Jan;6(1):51-7
references: 20088729
references: J Neurosci. 2004 Jun 9;24(23):5315-21
references: 15190103
references: J Cereb Blood Flow Metab. 2000 Apr;20(4):631-52
references: 10779008
references: J Neurochem. 2001 Jun;77(5):1319-26
references: 11389183
references: Stroke. 1997 Oct;28(10):1913-8
references: 9341695
references: J Cereb Blood Flow Metab. 1990 Mar;10(2):290-3
references: 1689322
references: Stroke. 2005 Feb;36(2):193-5
references: 15625289
references: Stroke. 2005 Mar;36(3):665-9
references: 15705940
references: Mol Cell Endocrinol. 2012 Apr 16;352(1-2):79-91
references: 21704118
references: J Cereb Blood Flow Metab. 2009 Aug;29(8):1454-62
references: 19436313
references: Brain Res. 2007 Sep 19;1170:97-102
references: 17698046
references: J Cereb Blood Flow Metab. 2007 Sep;27(9):1553-62
references: 17311081
references: J Steroid Biochem Mol Biol. 2005 Jun;96(1):89-91
references: 15896953
references: Biochem Biophys Res Commun. 2011 Jun 17;409(4):808-13
references: 21624354
references: J Urol. 2006 Jan;175(1):130-5
references: 16406889
references: Neuroscience. 2006;138(3):1015-20
references: 16310318
references: J Appl Physiol (1985). 2002 Jan;92(1):195-201
references: 11744660
references: Neuroscience. 2001;108(2):331-40
references: 11734365
references: Neuroscientist. 2009 Aug;15(4):324-32
references: 19359672
references: Eur Neurol. 2003;50(2):78-84
references: 12944711
references: Endocrinology. 2007 May;148(5):2458-64
references: 17303658
references: Eur J Neurosci. 1999 Apr;11(4):1285-91
references: 10103123
references: Exp Neurol. 2009 May;217(1):210-8
references: 19268668
references: Stroke. 2003 Feb;34(2):338-41
references: 12574529
references: J Transl Med. 2008 Jun 23;6:33
references: 18573200
references: Neurol Res Int. 2012;2012:867531
references: 22474588
references: Arterioscler Thromb Vasc Biol. 1996 Jun;16(6):749-54
references: 8640402
references: Endocrinology. 2007 Jun;148(6):2936-43
references: 17347309
references: Stroke. 2009 Apr;40(4):1082-90
references: 19211488
references: Lancet. 2012 Jul 28;380(9839):349-57
references: 22691567
references: J Ethnopharmacol. 2011 Dec 8;138(3):774-9
references: 22051882
references: Stroke. 2006 Feb;37(2):577-617
references: 16432246
references: Arch Ital Biol. 2006 May;144(2):63-73
references: 16642786
references: Brain Res. 2012 Jan 9;1430:93-100
references: 22119394
references: J Neuroimmunol. 2011 Aug 15;237(1-2):4-12
references: 21777982
references: Endocrine. 2006 Apr;29(2):209-15
references: 16785597
references: Neurology. 2001;57(5 Suppl 2):S31-4
references: 11552052
references: J Biol Chem. 1995 Aug 25;270(34):19998-20003
references: 7650017
references: Brain Res. 2001 Feb 23;892(2):255-62
references: 11172772